Advertisement

Topics

Rheumatoid arthritis: DMARD de-escalation — let the patient guide you

06:57 EDT 10 Aug 2017 | Nature Publishing

The DRESS study has shown that safety and efficacy were maintained for up to 3 years upon disease activity-guided dose reduction of TNF inhibitors. However, which patients are ideally suited for de-escalation remains to be investigated.

Original Article: Rheumatoid arthritis: DMARD de-escalation — let the patient guide you

NEXT ARTICLE

More From BioPortfolio on "Rheumatoid arthritis: DMARD de-escalation — let the patient guide you"

Quick Search
Advertisement
 

Relevant Topic

Cytokine Tumour Necrosis Factor (TNF)
TNF is a compound that is classified as a cytokine which plays a central role in the cellular mechanisms of apoptosis or cell death. However, there are a number of different kinds of TNF, just under twenty, but the family of molecules have very similar a...